0000939767-20-000072.txt : 20200508
0000939767-20-000072.hdr.sgml : 20200508
20200508211431
ACCESSION NUMBER: 0000939767-20-000072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200507
FILED AS OF DATE: 20200508
DATE AS OF CHANGE: 20200508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FELDBAUM CARL B
CENTRAL INDEX KEY: 0001326377
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 20862366
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY, PO BOX 511
CITY: SOUTH SAN FRISCISCO
STATE: CA
ZIP: 94083-0511
FORMER NAME:
FORMER CONFORMED NAME: Feldbaum Carl B
DATE OF NAME CHANGE: 20050506
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_158898685314353.xml
FORM 4
X0306
4
2020-05-07
0
0000939767
EXELIXIS, INC.
EXEL
0001326377
FELDBAUM CARL B
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
1
0
0
0
Common Stock
2020-05-07
4
M
0
11546
5.82
A
20067
D
Common Stock
2020-05-07
4
M
0
20000
3.38
A
40067
D
Common Stock
2020-05-07
4
S
0
31546
25.02
D
8521
D
Option (right to buy)
5.82
2020-05-07
4
M
0
11546
0
D
2013-12-06
2020-12-05
Common Stock
11546.0
0
D
Option (right to buy)
3.38
2020-05-07
4
M
0
20000
0
D
2014-05-29
2021-05-28
Common Stock
20000.0
20000
D
The option, representing the right to purchase a total of 43,546 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013.
The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2020-05-08